- Home
- CGTX vs SGA Comparison
CGTX vs SGA Comparison
Compare CGTX & SGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGTX
- SGA
- Stock Information
- Founded
- CGTX 2007
- SGA 1986
- Country
- CGTX United States
- SGA United States
- Employees
- CGTX N/A
- SGA N/A
- Industry
- CGTX Biotechnology: Pharmaceutical Preparations
- SGA Broadcasting
- Sector
- CGTX Health Care
- SGA Consumer Discretionary
- Exchange
- CGTX Nasdaq
- SGA Nasdaq
- Market Cap
- CGTX 79.3M
- SGA 89.2M
- IPO Year
- CGTX 2021
- SGA 1992
- Fundamental
- Price
- CGTX $0.44
- SGA $12.62
- Analyst Decision
- CGTX Buy
- SGA
- Analyst Count
- CGTX 6
- SGA 0
- Target Price
- CGTX $8.00
- SGA N/A
- AVG Volume (30 Days)
- CGTX 476.7K
- SGA 16.0K
- Earning Date
- CGTX 11-13-2024
- SGA 11-07-2024
- Dividend Yield
- CGTX N/A
- SGA 8.02%
- EPS Growth
- CGTX N/A
- SGA N/A
- EPS
- CGTX N/A
- SGA 0.75
- Revenue
- CGTX N/A
- SGA $110,669,000.00
- Revenue This Year
- CGTX N/A
- SGA $0.49
- Revenue Next Year
- CGTX N/A
- SGA $0.18
- P/E Ratio
- CGTX N/A
- SGA $16.82
- Revenue Growth
- CGTX N/A
- SGA N/A
- 52 Week Low
- CGTX $0.34
- SGA $11.71
- 52 Week High
- CGTX $2.95
- SGA $27.00
- Technical
- Relative Strength Index (RSI)
- CGTX 41.17
- SGA 39.51
- Support Level
- CGTX $0.43
- SGA $11.71
- Resistance Level
- CGTX $0.48
- SGA $14.09
- Average True Range (ATR)
- CGTX 0.04
- SGA 0.41
- MACD
- CGTX -0.01
- SGA -0.08
- Stochastic Oscillator
- CGTX 7.26
- SGA 38.24
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
About SGA Saga Communications Inc. (FL)
Saga Communications Inc is a broadcast company engaged in acquiring, developing, and operating broadcast properties. The company's objective is to operate top billing radio stations in mid-sized markets and It derives a majority of its revenue from the sale of advertising for broadcast on its stations.